Synthesis and Evaluation of Rutin–Hydroxypropyl β-Cyclodextrin Inclusion Complexes Embedded in Xanthan Gum-Based (HPMC-g-AMPS) Hydrogels for Oral Controlled Drug Delivery
Antioxidants · 22.02.2023 · 12 (3) · 552
DOI: 10.3390/antiox12030552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 22.02.2023. Verfasst von Abid Naeem und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Modern Preparation of Traditional Chinese Medicines, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004…. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangxi University of Chinese Medicine Science and Technology Innovation Team Development Program, Jiangxi university of traditional Chinese medicine 1050 youth talent project, Jiangxi University of Chinese Medicine Science and Technology Innovation Team Development.
Abstract (Originalsprache)
Oxidants play a significant role in causing oxidative stress in the body, which contributes to the development of diseases. Rutin—a powerful antioxidant—may be useful in the prevention and treatment of various diseases by scavenging oxidants and reducing oxidative stress. However, low solubility and oral bioavailability have restricted its use. Due to the hydrophobic nature of rutin, it cannot be easily loaded inside hydrogels. Therefore, first rutin inclusion complexes (RIC) with hydroxypropyl-β-cyclodextrin (HP-βCD) were prepared to improve its solubility, followed by incorporation into xanthan gum-based (hydroxypropyl methylcellulose-grafted-2-acrylamido -2-methyl-1-propane sulfonic acid) hydrogels for controlled drug release in order to improve the bioavailability. Rutin inclusion complexes and hydrogels were validated by FTIR, XRD, SEM, TGA, and DSC. The highest swelling ratio and drug release occurred at pH 1.2 (28% swelling ratio and 70% drug release) versus pH 7.4 (22% swelling ratio, 65% drug release) after 48 h. Hydrogels showed high porosity (94%) and biodegradation (9% in 1 week in phosphate buffer saline). Moreover, in vitro antioxidative and antibacterial studies (Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli) confirmed the antioxidative and antibacterial potential of the developed hydrogels.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Modern Preparation of Traditional Chinese Medicines, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
- School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
ORCID-Profile: Yongmei Guan
Förderung
- Jiangxi University of Chinese Medicine Science and Technology Innovation Team Development Program
- Jiangxi university of traditional Chinese medicine 1050 youth talent project
- Jiangxi University of Chinese Medicine Science and Technology Innovation Team Development
- Jiangxi university of traditional Chinese medicine 1050 youth talent
Zitieren
APA
Naeem, A., Yu, C., Zang, Z., Zhu, W., Deng, X., & Guan, Y. (2023). Synthesis and Evaluation of Rutin–Hydroxypropyl β-Cyclodextrin Inclusion Complexes Embedded in Xanthan Gum-Based (HPMC-g-AMPS) Hydrogels for Oral Controlled Drug Delivery. Antioxidants, 12(3), 552. https://doi.org/10.3390/antiox12030552
Vancouver
Naeem A, Yu C, Zang Z, Zhu W, Deng X, Guan Y. Synthesis and Evaluation of Rutin–Hydroxypropyl β-Cyclodextrin Inclusion Complexes Embedded in Xanthan Gum-Based (HPMC-g-AMPS) Hydrogels for Oral Controlled Drug Delivery. Antioxidants. 2023;12(3):552. doi:10.3390/antiox12030552
BibTeX
@article{Naeem2023,
author = {Naeem, Abid and Yu, Chengqun and Zang, Zhenzhong and Zhu, Weifeng and Deng, Xuezhen and Guan, Yongmei},
title = {Synthesis and Evaluation of Rutin–Hydroxypropyl β-Cyclodextrin Inclusion Complexes Embedded in Xanthan Gum-Based (HPMC-g-AMPS) Hydrogels for Oral Controlled Drug Delivery},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {3},
pages = {552},
doi = {10.3390/antiox12030552}
}
EUVIMED